
This document pertains to the final version of the Duopharma Unihepa A4 DA packaging, dated September 29, 2023. It includes both front and back designs of the packaging.
The packaging is designed for the Unihepa A4 DA pharmaceutical product by Duopharma. Key specifications include the layout dimensions (A4 size), color schemes, branding elements, and regulatory information placement.
The front side features the product name prominently, company logo, and essential product information such as dosage and usage instructions. The back side contains detailed information including ingredients, warnings, storage instructions, and manufacturer details.
The packaging adheres to pharmaceutical labeling standards, ensuring all mandatory information is clearly visible and legible. This includes batch numbers, expiry dates, and safety warnings.
The document emphasizes the importance of maintaining color accuracy and print quality to ensure brand consistency and regulatory compliance. It also recommends quality checks before mass production.
RENAL CARE FRANCHISE
Open the catalog to page 1> Prophylaxis and treatment of venous thrombosis and pulmonary embolism > Treatment of myocardial infarction and arterial embolism > Prevention of clotting in arterial and heart surgery > Prevention of cerebral thrombosis > Anticoagulant in blood transfusions, extracorporeal circulation, dialysis procedures, and for laboratory purposes Protect from light Protect from freezing V A vial can be stored for up to 28 days at 30°C following first withdrawal, provided the solution withdrawn with strict aseptic technique Composition: Each ml contains: Heparin Sodium BP (Bovine Mucosa) 5000 IU. Preservative:...
Open the catalog to page 24 Pages
18 Pages
2 Pages
2 Pages